Literature DB >> 16972798

A novel proteolytically processed CDP/Cux isoform of 90 kDa is generated by cathepsin L.

Brigitte Goulet1, Mary Truscott, Alain Nepveu.   

Abstract

The Cut-like genes code for multiple isoforms of the CDP/Cux transcription factor. The full-length protein contains four DNA-binding domains: Cut repeats 1, 2 and 3 (CR1, CR2 and CR3) and the Cut homeodomain (HD). The p75 isoform is expressed from an mRNA that is initiated within intron 20 and contains only CR3 and HD. The p110 isoform is generated by proteolytic processing by cathepsin L and contains CR2, CR3 and HD. In the present study, we show that an additional isoform of 90 kDa is expressed in many cell lines of epithelial origin. Mapping experiments with deletion mutants indicated that the N-terminus of p90 is located upstream of CR2, between amino acids 918 and 938. Indeed, p90 and p110 displayed similar DNA-binding and transcriptional activities. The p90 isoform, like p110, was found to be generated by proteolytic processing. The steady-state level of both p90 and p110 correlated with the level of cathepsin L activity. Importantly, co-expression with a cathepsin L mutant that is initiated at downstream AUG sites also stimulated the generation of p90 and p110. These results strongly suggest that p90, like p110, is generated by cathepsin L isoforms that are devoid of a signal peptide.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16972798     DOI: 10.1515/BC.2006.159

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  16 in total

1.  Nuclear cysteine cathepsin variants in thyroid carcinoma cells.

Authors:  Sofia Tedelind; Kseniia Poliakova; Amanda Valeta; Ruth Hunegnaw; Eyoel Lemma Yemanaberhan; Nils-Erik Heldin; Junichi Kurebayashi; Ekkehard Weber; Nataša Kopitar-Jerala; Boris Turk; Matthew Bogyo; Klaudia Brix
Journal:  Biol Chem       Date:  2010-08       Impact factor: 3.915

Review 2.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

3.  p110 CUX1 cooperates with E2F transcription factors in the transcriptional activation of cell cycle-regulated genes.

Authors:  Mary Truscott; Ryoko Harada; Charles Vadnais; François Robert; Alain Nepveu
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

4.  Further characterization of the signaling proteolysis step in the Aspergillus nidulans pH signal transduction pathway.

Authors:  María M Peñas; América Hervás-Aguilar; Tatiana Múnera-Huertas; Elena Reoyo; Miguel A Peñalva; Herbert N Arst; Joan Tilburn
Journal:  Eukaryot Cell       Date:  2007-04-06

5.  Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells.

Authors:  Catera L Wilder; Charlene Walton; Valencia Watson; Fermin A A Stewart; Jade Johnson; Shelly R Peyton; Christine K Payne; Valerie Odero-Marah; Manu O Platt
Journal:  Int J Biochem Cell Biol       Date:  2016-08-31       Impact factor: 5.085

6.  A novel cysteine cathepsin inhibitor yields macrophage cell death and mammary tumor regression.

Authors:  S J Salpeter; Y Pozniak; E Merquiol; Y Ben-Nun; T Geiger; G Blum
Journal:  Oncogene       Date:  2015-03-23       Impact factor: 9.867

7.  The transcription factor Cux1 in cerebellar granule cell development and medulloblastoma pathogenesis.

Authors:  Sabine Topka; Alexander Glassmann; Gunnar Weisheit; Ulrich Schüller; Karl Schilling
Journal:  Cerebellum       Date:  2014-12       Impact factor: 3.847

8.  Anaplasma phagocytophilum increases cathepsin L activity, thereby globally influencing neutrophil function.

Authors:  Venetta Thomas; Swapna Samanta; Erol Fikrig
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

9.  p110 CUX1 homeodomain protein stimulates cell migration and invasion in part through a regulatory cascade culminating in the repression of E-cadherin and occludin.

Authors:  Valerie Kedinger; Laurent Sansregret; Ryoko Harada; Charles Vadnais; Chantal Cadieux; Kelly Fathers; Morag Park; Alain Nepveu
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

10.  Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.

Authors:  Liza J Burton; Jodi Dougan; Jasmine Jones; Bethany N Smith; Diandra Randle; Veronica Henderson; Valerie A Odero-Marah
Journal:  Mol Cell Biol       Date:  2017-02-15       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.